# OnCo record paper-seddon-lancet-oncol (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-seddon-lancet-oncol/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-seddon-lancet-oncol" ;
  schema:name "Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial"@en ;
  schema:description "Paper cited by one cancer page, indexed on Europe PMC as PubMed record 28882536 and published in The Lancet Oncology; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-seddon-lancet-oncol/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s1470-2045(17)30622-8>, <https://pubmed.ncbi.nlm.nih.gov/28882536/>, <https://europepmc.org/article/MED/28882536> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s1470-2045(17)30622-8> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Seddon B, Strauss SJ, Whelan J, et al." ;
  onco:related <https://onco.cc/cancers/uterine-sarcoma/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .